- 4.9Impact Factor
- 9.0CiteScore
- 21 daysTime to First Decision
Cognitive Impairment in Neurological Diseases
This special issue belongs to the section “Molecular Neurobiology“.
Special Issue Information
Dear Colleagues,
Cognitive impairment is a commonly observed symptom of neurodegenerative and other neurological diseases. The majority of patients with neurological diseases such as Alzheimer’s disease, Parkinson’s disease, epilepsy, multiple sclerosis, stroke and head injury develop cognitive impairment, often early during their disease course, which may become more severe with disease progression.
Cognitive impairment may affect several domains such as memory, executive function, attention, processing speed, etc. Moreover, it is well known that cognitive impairment, in particular, in dementia, is an important source of disability and reduction in quality of life for both patients and caregivers.
The scope of this Special Issue is to provide some insight on recent developments and to further present some comprehensive reviews on specific aspects of cognitive impairment. In particular, presenting and examining the patterns of cognitive impairment observed in several neurological diseases, as well as their molecular biology and pathophysiology and methods for accurate diagnoses of cognitive impairment such as neuropsychometric tests, blood tests, neuroimaging and clinical neurophysiology techniques are of major interest. We welcome contributions in the form of original research articles, reviews and communications.
Dr. Vasileios Papaliagkas
Dr. Julian Benito-Leon
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cognitive impairment
- neurological diseases
- Alzheimer’s disease
- mild cognitive impairment
- epilepsy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

